HOME › DRUGS › ZIDOVUDINE
ACTIVE SUBSTANCE / INN

ZIDOVUDINE

Brand name(s): COMBIVIR, ZIDOVUDINE, LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETS, RETROVIR, LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE, LAMIVUDINE; ZIDOVUDINE, LAMIVUDINE AND ZIDOVUDINE, ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA205626
ANDA079079
ACTIVE SUBSTANCE
Zidovudine
REGULATORS
FDA
SPONSORS / MAH
LUPIN LTD, PHARMOBEDIENT, CIPLA
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ZIDOVUDINEANDA076844HIKMADiscontinued
ZIDOVUDINEANDA090561CIPLAPrescription
LAMIVUDINE AND ZIDOVUDINEANDA090679MACLEODS PHARMS LTDPrescription
LAMIVUDINE; ZIDOVUDINENDA201151CIPLA LIMITEDNone (Tentative Approval)
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINEANDA202912LUPIN LTDDiscontinued
LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINENDA205626MICRO LABSDiscontinued
COMBIVIRNDA020857VIIV HLTHCAREDiscontinued
LAMIVUDINE AND ZIDOVUDINEANDA079079PHARMOBEDIENTDiscontinued
LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE TABLETSNDA200793MATRIX LABSNone (Tentative Approval)
RETROVIRNDA020518VIIV HLTHCAREDiscontinued

FULL INTELLIGENCE ON ZIDOVUDINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →